FDA Delays Force Kezar Life Sciences to Shut Down
Kezar Life Sciences is winding down after FDA meeting cancellations disrupted its autoimmune hepatitis drug program, driving investors to withdraw funding.
Fda Regulatory Delays
1 article tagged "Fda Regulatory Delays"